Tumor necrosis factor-receptor 2 and troy gene expression patterns in cutaneous squamous cell carcinoma in a Tunisian population

Saudi Medical Journal

Volumn 32, Issue 11, 2011, Pages 1202-1203

  Zidi, Ines T ^a,b   M'farrej, Souhir M ^b   Bergaoui, Sameh D ^b   Ghariani, Nejet Z ^c   Bartegi, Aghleb B ^a,b   ben Amor, Nidhal N ^a,b   Nouira, Rafia B ^c  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF MONASTIR   (Tunisia)

^c FARHAT HACHED HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; TROY PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; CUTANEOUS SQUAMOUS CELL CARCINOMA; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; MELANOMA; OVARY CARCINOMA; SQUAMOUS CELL CARCINOMA; TUNISIA;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; DNA PRIMERS; HUMANS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SKIN NEOPLASMS; TUNISIA;

EID: 81755187375     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Clayman GL, Lee JJ, Holsinger FC, Zhou X, Duvic M, El- Naggar AK, et al. Mortality risk from squamous cell skin cancer. J Clin Oncol 2005; 23: 759-765.
2. Malejczyk M, Józwiak J, Jablonska S, Pfister H, Majewski S, Malejczyk J. Circulating soluble tumour necrosis factor receptors in patients with epidermodysplasia verruciformis as compared to patients with cutaneous tumours in the general population. Oncol Rep 2005; 13: 151-155.
3. Arnott CH, Scott KA, Moore RJ, Robinson SC, Thompson RG, Balkwill FR. Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development. Oncogene 2004; 23: 1902-1910.
4. Spanjaard RA, Whren KM, Graves C, Bhawan J. Tumor necrosis factor receptor superfamily member TROY is a novel melanoma biomarker and potential therapeutic target. Int J Cancer 2007; 120: 1304-1310.
5. Hashimoto T, Schlessinger D, Cui CY. Troy binding to lymphotoxin-alpha activates NFkappa B mediated transcription. Cell Cycle 2008; 7: 106-111.